Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endothelial Degeneration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT04058236
What this trial is testing

Glycocalyx Levels in Patients Undergoing Pancreatectomy

Who this might be right for
Endothelial DegenerationPancreatic CancerPancreatectomy+1 more
University of Malaya 20
Post-approval studies (Phase 4)Ended earlyNCT05473715
What this trial is testing

Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Bayer 3
Testing effectiveness (Phase 2)Study completedNCT01535950
What this trial is testing

Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-elated Macular Degeneration (Wet AMD)Exudative Macular Degeneration
Novartis Pharmaceuticals 43
Not applicableEnded earlyNCT01746875
What this trial is testing

A Study Testing if Medicine Can Make Pigment Epithelium Detachments Regress and Stabilize the Vision in Eyes

Who this might be right for
Macular DegenerationRetinal Detachment
Norwegian University of Science and Technology 9
Large-scale testing (Phase 3)Study completedNCT01661946
What this trial is testing

Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

Who this might be right for
Diabetic Macular Edema
Queen's University 10
Large-scale testing (Phase 3)Study completedNCT00509795
What this trial is testing

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 1,217
Large-scale testing (Phase 3)Active Not RecruitingNCT05407636
What this trial is testing

Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+3 more
AbbVie 735
Not applicableStudy completedNCT03679156
What this trial is testing

Retinal Pigment Epithelial Characteristics in Eyes With Neovascular Age-related Macular Degeneration Following Long-term Treatment With Anti Neovascular Endothelial Growth Factor

Who this might be right for
Neovascular Age-related Macular Degeneration
Hospital Hietzing 18
Testing effectiveness (Phase 2)Study completedNCT00320788
What this trial is testing

Safety and Efficacy of Repeated Intravitreal Administration of Vascular Endothelial Growth Factor (VEGF) Trap in Patients With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Macular Degeneration
Regeneron Pharmaceuticals 159
Large-scale testing (Phase 3)Study completedNCT04592419
What this trial is testing

Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Patients With Macular Edema Due to Retinal Vein Occlusion (RVO)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Kodiak Sciences Inc 568
Not applicableStudy completedNCT04138420
What this trial is testing

Evaluation of Retinal and Vascular Features in Macular Degeneration After Intravitreal Injections of Bevacizumab

Who this might be right for
Exudative Age-related Macular Degeneration
Federico II University 38
Not applicableStudy completedNCT03313401
What this trial is testing

Effect of Aflibercept on Human Corneal Endothelial Cells in Neovascular Age-Related Macular Degeneration

Who this might be right for
Age Related Macular Degeneration
Ulucanlar Eye Training and Research Hospital 34
Very early researchLooking for participantsNCT06031727
What this trial is testing

CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)

Who this might be right for
Neovascular Age-related Macular Degeneration(nAMD)
HuidaGene Therapeutics Co., Ltd. 12
Large-scale testing (Phase 3)Ended earlyNCT03802630
What this trial is testing

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion
Novartis Pharmaceuticals 450
Large-scale testing (Phase 3)Study completedNCT01436864
What this trial is testing

A Randomized, Double-masked, Multicenter,Sham-controlled, Safety and Efficacy Study of KH902 in Patients With Wet AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 125
Post-approval studies (Phase 4)Looking for participantsNCT04853251
What this trial is testing

A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)

Who this might be right for
Neovascular Age-related Macular Degeneration
Genentech, Inc. 188
Post-approval studies (Phase 4)Study completedNCT00504959
What this trial is testing

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Who this might be right for
Subfoveal Choroidal Neovascularization (CNV)Secondary to Age-related Macular Degeneration (AMD)
Novartis 234
Not applicableStudy completedNCT02251366
What this trial is testing

NVAMD Satellite Study

Who this might be right for
Neovascular Age Related Macular Degeneration
Johns Hopkins University 66
Early research (Phase 1)Ended earlyNCT03396861
What this trial is testing

Treatment of Macular Edema After Cataract Surgery with Subconjunctival Aflibercept

Who this might be right for
Irvine-Gass Syndrome
Tufts Medical Center 1
Not applicableStudy completedNCT01918371
What this trial is testing

A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Who this might be right for
Retinal Vein OcclusionMacular Edema
Allergan 323
Next Page